Hector Tamez, MD MPH (@hectortamezmd) 's Twitter Profile
Hector Tamez, MD MPH

@hectortamezmd

Interventional Cardiology at BIDMC & @harvardmed. Interests: CHIP & CTOs Photographer hectortamez.com swimmer. Opinions my own.

ID: 4244466831

linkhttps://connects.catalyst.harvard.edu/Profiles/display/Person/15162 calendar_today21-11-2015 20:14:51

3,3K Tweet

2,2K Followers

591 Following

Nora Neus (@noraneus) 's Twitter Profile Photo

He's back! John Berman is finally out of the hospital and with us on @NewDay. Here he explains his ordeal over the last week... with a very important note that you can still donate to #TeamBeans john.teambeansmarathon.com

Hector Tamez, MD MPH (@hectortamezmd) 's Twitter Profile Photo

. Robert W. Yeh : that is aggressive guide, etc. who did that case? Was it me? Me: no, I think it was me… Robert W. Yeh checks the chart: he was attending and I was fellow

jedicath աǟզǟʀ.ǟɦʍɛɖ (@jedicath) 's Twitter Profile Photo

A balloon non-crossable lesion By jedicath աǟզǟʀ.ǟɦʍɛɖ & MIЯVΛƬ #IC 71 year old pt cath outside for real class 3 angina. Heavily calcified LM and LAD ostium with disease plus mid LAD disease (LRV) Small LCX CTO and a large RCA CTO. EF 40% surgical turn down due to mobility 1/n

Eric Secemsky MD MSc (@ericsecemskymd) 's Twitter Profile Photo

1/Today published in JACC Journals is the 1st global consensus document on IVUS use for lower ext arterial & venous revasc. This document involved >40 international multidisciplinary experts in vascular disease & was led by a 12 person steering committee. bit.ly/3A7bcTY

1/Today published in <a href="/JACCJournals/">JACC Journals</a> is the 1st global consensus document on IVUS use for lower ext arterial &amp; venous revasc. This document involved &gt;40 international multidisciplinary experts in vascular disease &amp; was led by a 12 person steering committee.

bit.ly/3A7bcTY
Robert W. Yeh (@rwyeh) 's Twitter Profile Photo

Superhuman effort by Eric Secemsky MD MSc Sahil A. Parikh, MD and colleagues to bring this global consensus together regarding use of intravascular imaging to support lower extremity catheter-based interventions. The field will benefit from this important document!

Robert W. Yeh (@rwyeh) 's Twitter Profile Photo

I keep running into the BIDMC CV Fellowship congregating at weird hours in strange corners of the hospital, dressed like attendings. #skitnightcoming #thatsnotHector #iveneveryelledatanyofyou

I keep running into the <a href="/BIDMCVFellows/">BIDMC CV Fellowship</a> congregating at weird hours in strange corners of the hospital, dressed like attendings.

#skitnightcoming
#thatsnotHector
#iveneveryelledatanyofyou
Eric Secemsky MD MSc (@ericsecemskymd) 's Twitter Profile Photo

1/In January 2021, BIDMC Smith Center was engaged to see if timely, rigorous real-world evidence can be generated about a specific aortic stent graft that had concerns for complications but little long-term data. These data would be used for an Advisory panel later in the year. Robert W. Yeh

1/In January 2021, <a href="/SmithBIDMC/">BIDMC Smith Center</a> was engaged to see if timely, rigorous real-world evidence can be generated about a specific aortic stent graft that had concerns for complications but little long-term data. These data would be used for an Advisory panel later in the year. <a href="/rwyeh/">Robert W. Yeh</a>
MyJSCAI (@myjscai) 's Twitter Profile Photo

NCDR CathPCI: #CTO #PCI vs. high risk non-CTO PCI: -CTO PCI has lower success & higher in-hospital event rates -CTO PCI has lower risk of long-term events ➡️doi.org/10.1016/j.jsca… Robert W. Yeh Zaid Almarzooq Eric Secemsky MD MSc @ajaykirtane Hector Tamez, MD MPH

NCDR CathPCI: #CTO #PCI vs. high risk non-CTO PCI: 
-CTO PCI has lower success &amp; higher in-hospital event rates
-CTO PCI has lower risk of long-term events

➡️doi.org/10.1016/j.jsca… 

<a href="/rwyeh/">Robert W. Yeh</a> <a href="/ZaidAlMarzooq/">Zaid Almarzooq</a> <a href="/EricSecemskyMD/">Eric Secemsky MD MSc</a> @ajaykirtane  <a href="/hectortamezmd/">Hector Tamez, MD MPH</a>
Dhruv Kazi (@kardiologykazi) 's Twitter Profile Photo

The proposed “Most Favored Nation Drug Pricing” (MFN-DP) plan is the most ambitious plan yet to rein in US drug spending. How did we get here? How would MFN-DP work? What are the expected short, intermediate, & long-term consequences? Here are my top 10 takeaways (so far)- 1/

The proposed  “Most Favored Nation Drug Pricing” (MFN-DP) plan is the most ambitious plan yet to rein in US drug spending. 

How did we get here? How would MFN-DP work? What are the expected short, intermediate, &amp; long-term consequences?

Here are my top 10 takeaways (so far)-
1/